| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.07 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,840,628 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,171,858 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
25 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Link Max |
Director |
– • – |
2004-12-30 |
4 |
OE |
$6.63 |
$99,450 |
D/D |
15,000 |
68,572 |
|
- |
|
| Leigh Richard Jr |
EVP, General Counsel |
• – – |
2004-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
13,300 |
|
- |
|
| Aselage Steve |
EVP Global Comm Operations |
• – – |
2004-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
30,000 |
|
- |
|
| Canfield James |
Chief Administrative Officer |
• – – |
2004-12-13 |
4 |
AS |
$7.55 |
$25,172 |
D/D |
(3,334) |
57,166 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2004-12-13 |
4 |
AS |
$7.55 |
$12,080 |
D/D |
(1,600) |
346,876 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2004-12-13 |
4 |
AS |
$7.55 |
$50,336 |
D/D |
(6,667) |
116,397 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2004-12-10 |
4 |
S |
$7.50 |
$151,173 |
D/D |
(20,000) |
574,597 |
|
- |
|
| Leigh Richard Jr |
Exec. V.P., General Counsel |
• – – |
2004-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2004-08-25 |
4 |
OE |
$2.91 |
$63,656 |
D/D |
21,905 |
49,905 |
|
- |
|
| Aselage Steve |
EVP Global Commercial Ops |
• – – |
2004-08-03 |
4 |
B |
$5.25 |
$21,000 |
D/D |
4,000 |
20,000 |
2.74 |
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2004-07-01 |
4 |
AS |
$7.25 |
$29,001 |
D/D |
(4,000) |
123,064 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2004-07-01 |
4 |
AS |
$7.25 |
$72,500 |
D/D |
(10,000) |
594,597 |
|
- |
|
| Canfield James |
Chief Administrative Officer |
• – – |
2004-07-01 |
4 |
AS |
$7.26 |
$7,260 |
D/D |
(1,000) |
60,500 |
|
- |
|
| Canfield James |
EVP, Chief Admin. Officer |
• – – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
61,500 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
348,476 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
127,064 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
604,597 |
|
- |
|
| Aselage Steve |
EVP, Global Commercial Ops |
• – – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
16,000 |
|
- |
|
| Aselage Steve |
EVP, Global Commercial Ops |
• – – |
2004-02-18 |
4 |
B |
$8.90 |
$54,000 |
D/D |
6,000 |
6,000 |
2.74 |
- |
|
| Spinelli Silvano |
EVP, Development |
• • – |
2004-01-05 |
4 |
S |
$9.64 |
$407,500 |
I/I |
(40,000) |
136,000 |
|
- |
|
| Singer Jack W |
EVP, Research Program Chairman |
• • – |
2004-01-05 |
4 |
AS |
$10.00 |
$50,000 |
D/D |
(5,000) |
333,476 |
|
- |
|
| Singer Jack W |
EVP, Research Program Chairman |
• • – |
2004-01-05 |
4 |
OE |
$2.91 |
$14,530 |
D/D |
5,000 |
0 |
|
- |
|
| Spinelli Silvano |
EVP, Development |
• • – |
2004-01-02 |
4 |
S |
$9.57 |
$191,400 |
I/I |
(20,000) |
176,000 |
|
- |
|
| Spinelli Silvano |
EVP, Development |
• • – |
2004-01-02 |
4/A |
S |
$9.52 |
$190,400 |
I/I |
(20,000) |
176,000 |
|
- |
|
| Canfield James |
Chief Administrative Officer |
• – – |
2004-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
36,500 |
|
- |
|
742 Records found
|
|
Page 29 of 30 |
|
|
